Menu
01. Doctor Overview

Doctor Overview

Dr. Daniel Labow is a board-certified surgeon with a specialty in surgical oncology. He is the Chairman of Surgery at Mount Sinai West and Mount Sinai Morningside, the Vice Chair of Outpatient Services for the Department of Surgery and the Program Director of Surgical Oncology Fellowship. As a graduate of Brown University, Dr. Labow completed his Residency in General Surgery at the University of Chicago Hospitals and his Fellowship in Surgery Oncology at Memorial Sloan-Kettering Cancer Center.

Dr. Labow established and directs the Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) program at Mount Sinai Hospital. This technique, which combines surgery with chemotherapy, has revolutionized the treatment of cancers in the abdominal (peritoneal) lining that stem from colon, gastric, ovarian and appendiceal cancers, as well as mesothelioma and pseudomyxoma peritonei. HIPEC is a heated chemotherapy wash administered to the abdominal cavity after surgery to remove tumors and lesions.

Dr. Labow’s clinical and research interests include the diagnosis and treatment of a broad range of both primary and metastatic malignancies. This includes gastric and esophageal cancer, pancreatic neoplasms, primary and metastatic liver malignancies, biliary tract disease, colon and rectal cancer, sarcoma and melanoma. He also concentrates in the application of minimally invasive techniques and their role in cancer care.

In addition to Dr. Labow’s clinical work, he has been published in more than 75 peer-reviewed articles. Some of the medical journals he has been published in include Annals of Translational Medicine and American Cancer Society Journals.

02. Fast Facts

Doctor Fast Facts

Main Specialty: General Surgery and Surgical Oncology

Other Interests & Specialties: Appendix cancer, bile duct cancer, colorectal cancer, esophageal cancer, gallbladder cancer, gastrectomy, heated intraperitoneal chemotherapy (HIPEC), liver cancer, pancreatic cancer, radiofrequency ablation, small bowel cancer, soft tissue sarcoma, splenectomy, stomach cancer and surgery second opinion.

Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery, Chief Research Fellow for Memorial Sloan-Kettering Cancer Center in 1998, Administrative Chief Resident for University of Chicago Hospitals in 2001, New York Metro Area’s Top Doctors by Castle Connolly in 2011, New York Magazine’s 2013 Best Doctors

Education & Experience:

  • Medical Degree from Brown University
  • Residency in General Surgery at University of Chicago Hospitals
  • Fellowship in Surgery Oncology at Memorial Sloan-Kettering Cancer Center
03. Publications

Publications

Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. April 2020;126(11):2547-2552. doi: 10.1002/cncr.32870

Malignant peritoneal mesothelioma: a review. Annals of Translational Medicine. June 2017;5(11):236. doi: 10.21037/atm.2017.03.96